Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Effects of 0.01% Atropine in Adult Myopes
NCT06071260Unknown
- Sponsor
- He Eye Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of NVK002 in myopia, sponsored by He Eye Hospital. Primary endpoint: Change in pupil size at 20 hours. Status: unknown.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT06071260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06071260.